MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer
Understanding the nature and extent of non-canonical human leukocyte antigen (HLA) presentation in tumour cells is a priority for target antigen discovery for the development of next generation immunotherapies in cancer. We here employ a de novo mass spectrometric sequencing approach with a refined,...
Main Authors: | Liao, H, Barra, C, Zhou, Z, Peng, X, Woodhouse, I, Tailor, A, Parker, R, Carré, A, Borrow, P, Ternette, N, Hogan, MJ, Paes, W, Eisenlohr, LC, Mallone, R, Nielsen, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2024
|
Similar Items
-
MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer
by: Hanqing Liao, et al.
Published: (2024-01-01) -
Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer
by: Xu Peng, et al.
Published: (2023-03-01) -
Working on Mars : voyages of scientific discovery with the Mars exploration rovers /
by: Clancey, William J., author
Published: (c201) -
HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes
by: Karnaukhov, V, et al.
Published: (2022) -
Resenha de: O Novo Testamento: Cânon; línga; texto
by: Odilon Nogueira de Matos
Published: (1969-12-01)